Dr. Tarver has been acting director of the CDRH since late July, when Dr. Shuren, who had led the department for nearly 15 years, left the position. She previously served as the deputy director of strategic partnerships and technology innovation, and the program director of patient science and engagement. Dr. Tarver has been with the FDA since 2009.
Patient advocates told The New York Times they hope Dr. Tarver will lead the agency to focus more on safety and less on rapid approvals.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
